Publications
5538 Results
- Journal / Conference
- American Journal of Clinical Oncology 22(1):18-21
- Year
- 1999
- Research Committee(s)
- Cancer Control
Inclusion of black americans in oncology clinical trials: the Louisiana State University medical center experience.
- Journal / Conference
- Clinical Cancer Research 5:1077-1084
- Year
- 1999
- Research Committee(s)
- Leukemia
- Study Number(s)
- SWOG-8600
Estrogen receptor methylation is associated with improved survival in adult acute myeloid leukemia.
- Journal / Conference
- Cancer Immunology and Immunotherapy 48:533-539
- Year
- 1999
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- SWOG-9009
Association of immune parameters with clinical outcome in stage III colon cancer: Results of Southwest Oncology Group Protocol 9009.
- Journal / Conference
- Cancer Journal from Scientific American 5(1):41-47
- Year
- 1999
- Research Committee(s)
- Melanoma
- Study Number(s)
- SWOG-9223
A phase II evaluation of all trans-retinoic acid plus interferon alfa-2a in stage IV melanoma: A Southwest Oncology Group study.
- Journal / Conference
- Journal of Clinical Oncology 17(5):1339-1348
- Year
- 1999
- Research Committee(s)
- Gynecologic
- Study Number(s)
- SWOG-8695
Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stages IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: A Gynecologic Oncology Group and Southwest Oncology Group study.
- Journal / Conference
- Cancer Chemotherapy and Pharmacology 44:461-468
- Year
- 1999
- Research Committee(s)
- Lung
- Study Number(s)
- SWOG-9307
Treatment of poor prognosis extensive disease small cell lung cancer with an all-oral regimen of etoposide and cyclophosphamide - A Southwest Oncology Group clinical and pharmacokinetic study.
- Journal / Conference
- Modern Pathology 12(1):54-60
- Year
- 1999
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- SWOG-9008 (INT-0116) (RTOG-9018) (NCCTG-90-41-51) (ECOG-6290) (CALGB-9195)
p53 immunoreactivity and single-strand conformational polymorphism analysis often fail to predict p53 mutational status.
- Journal / Conference
- New England Journal of Medicine 340(4):265-271
- Year
- 1999
- Research Committee(s)
- Lung
- Study Number(s)
- SWOG-8991 (EST-3588) (RTOG-8815) (INT-0096)
Twice-daily compared with once-daily thoracic radiotherapy in limited small cell lung cancer treated concurrently with cisplatin and etoposide
- Journal / Conference
- Investigational New Drugs 16:331-332
- Year
- 1999
- Research Committee(s)
- Brain
- Study Number(s)
- SWOG-9110
Phase II study of didemnin B in central nervous system tumors: A Southwest Oncology Group study.
- Journal / Conference
- Cancer 86(5):775-781
- Year
- 1999
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- SWOG-9051